SABRINA MARTUCCI JOHNSON - 26 Jun 2025 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
Director
Signature
/s/ Ryan Barrett, Attorney-in-fact
Issuer symbol
ATAI
Transactions as of
26 Jun 2025
Net transactions value
$0
Form type
4
Filing time
27 Jun 2025, 17:31:27 UTC
Previous filing
31 Jan 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
JOHNSON SABRINA MARTUCCI Director C/O ATAI LIFE SCIENCES N.V., PROF. J.H. BAVINCKLAAN 7, AMSTERDAM, NETHERLANDS /s/ Ryan Barrett, Attorney-in-fact 27 Jun 2025 0001199102

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATAI Stock Option Award $0 +103,000 $0.000000 103,000 26 Jun 2025 Common Shares 103,000 $2.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest on the earlier of the day before the ATAI Life Sciences N.V's next annual meeting or June 26, 2026.